EGFR signaling as a mechanism of resistance to CDK4/6 inhibitors in Palbociclib-resistant ER plus breast cancer cellsNadiia Lypova,Lilibeth Lanceta,Susan M. Dougherty,Jason A. Chesney,Yoannis Imbert-FernandezCANCER RESEARCH(2022)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要